4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-23-008102
CEO sold 12,194 shares at $19.06 ($232,418)
From the SEC's structured data for this filing
Trades in this filing
Shah Gaurav · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-17 | Sale : show line 1 in the form | −12,194 | $19.06 | $232,418 | 536,885 | D |
| Open-market sales · 12,194 sh · avg $19.06 · $232,418 | ||||||
Loading xslF345X03/form4.xml…